Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy-Reference-Cited by-同舟云学术

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy

Published:1999-12 Issue:6 Volume:138 Page:1126-1132
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Murdoch David R.,McDonagh Theresa A.,Byrne John,Blue Lynda,Farmer Rosemary,Morton James J.,Dargie Henry J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival And Ventricular Enlargement trial: the SAVE Investigators;Pfeifer;N Engl J Med,1992

2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;SOLVD Investigators;N Engl J Med,1991

3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions;SOLVD Investigators;N Engl J Med,1992

4. Severity of heart failure and dosage of angiotensin converting enzyme inhibitors;Clark;BMJ,1995

5. Clinical outcome with enalapril in symptomatic chronic heart failure: a dose comparison;NETWORK Investigators;Eur Heart J,1998

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?;Current Heart Failure Reports;2023-09-07

2. Combined Left Ventricular Ejection Fraction and N-Terminal pro-B-type Natriuretic Peptide after Sacubitril/Valsartan for Predicting Outcomes in Patients with Heart Failure with Reduced Ejection Fraction;ACTA CARDIOL SIN;2023

3. Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level;Inflammopharmacology;2022-07-25

4. Biomarkers for the diagnosis and management of heart failure;Heart Failure Reviews;2021-04-14

5. Biomarkers for the diagnosis and management of heart failure: natriuretic peptides;G ITAL CARDIOL;2021